SERNOVA WKN: A0LBCR ISIN: CA81732W1041 Kürzel: SVA Forum: Aktien Thema: Hauptdiskussion

They lowered the dose of belatacept and tacrolimus without antimetabolite due to side effects of overimmunosuppression observed in the first patient from cohort2 and it did not work. "While the limited regimen was effective after IPITx, we found it deficient after Tx into SCPs, as robust CD3 infiltrates and complete islet graft failure were observed indicating cellular rejection in subsequent 4 patients."

Its like the Mini-disc tech, it was the best. For about 5 minutes. Sernovas 5 min will soon be gone. Our Board is a disaster. They and management will all move on, richer, leaving investors poorer. Sad part is that they will get away with it. Like so many before them while investors will feel the pain for a long time. Thieves. Shameful. Yes its a high risk stock but one would at least expect professionalism and honest communication to share owners. This company have none of that, not professionalism in conduct not honest communication. All they have is greedy people enriching themselves on the account of others. Its been a shit show the last couple of years and Im glad I only have lottery tickets with them now and cut some losses. But it still hurts. Especially with two family members having typ1.